BofA lowered the firm’s price target on Canopy Growth to C$4 from C$7 and keeps an Underperform rating on the shares after Canopy reported Q3 net sales that beat the firm’s and Visible Alpha estimates. While BofA sees an improved sales outlook and rightsizing aiding the stock, the company’s cash burn and lack of U.S. federal regulatory progress likely holds back additional investor interest, says the analyst, who cut the multiple the firm is applying to estimates given higher share count, updated net debt and revenue forecasts.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CGC:
- “More Consolidation Ahead,” Says Canopy Growth (TSE:WEED)
- Canopy Growth price target lowered to $3 from $5 at Piper Sandler
- Canopy Growth price target lowered to C$6 from C$10 at Alliance Global Partners
- Canopy Growth Reports Third Quarter Fiscal Year 2024 Financial Results; Achieves Third Quarter of Sequential Revenue Growth across Canada Cannabis Businesses and a Record Quarter for Medical Sales
- Options Volatility and Implied Earnings Moves Today, February 09, 2024